Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-20 @ 1:33 PM
Study NCT ID:
NCT00970359
Status:
COMPLETED
Last Update Posted:
2017-04-12
First Post:
2009-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-01
First Submit QC Date:
None
Study First Post Date:
2009-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-20
Results First Submit QC Date:
None
Results First Post Date:
2017-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-01
Last Update Post Date:
2017-04-12
Last Update Post Date Type:
ACTUAL